Editorial
Copyright ©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Mar 10, 2011; 2(3): 135-149
Published online Mar 10, 2011. doi: 10.5306/wjco.v2.i3.135
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Schematic representation of the epidermal growth factor receptor pathway. EGFR: Epidermal growth factor receptor; mAB: Monoclonal antibody; TKI: Tyrosine kinase inhibitor; mTOR: Mammalian target of rapamycin; PI3K: Phosphoinositide 3-kinases; MEK: MAP kinase or ERK kinase.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Schematic representation of the vascular endothelial growth factor pathway. VEGF: Vascular endothelial growth factor; PlGF: Placental growth factor; mAb: Monocolonal antibody; VEGFR: Vascular endothelial growth factor receptor; mTOR: Mammalian target of rapamycin; PI3K: Phosphoinositide 3-kinases; MEK: MAP kinase or ERK kinase; TKI: Tyrosine kinase inhibitor.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Schematic representation of the hedgehog pathway. Hh: Hedgehog; Ptch: Patched; Smo: Smoothened; Sufu: Fused and suppressor of fused.